4.7 Article

Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome

期刊

CELL STEM CELL
卷 27, 期 4, 页码 574-+

出版社

CELL PRESS
DOI: 10.1016/j.stem.2020.07.015

关键词

-

资金

  1. Stanford University, United States
  2. Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome from Mayo Clinic, United States
  3. NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, United States (The University of Washington Birth Defects Research Laboratory) [2R24HD000836-52]
  4. AHA from Amerian Heart Association, United States [20POST35210924]

向作者/读者索取更多资源

Hypoplastic left heart syndrome (HLHS) is a complex congenital heart disease characterized by abnormalities in the left ventricle, associated valves, and ascending aorta. Studies have shown intrinsic myocardial defects but do not sufficiently explain developmental defects in the endocardial-derived cardiac valve, septum, and vasculature. Here, we identify a developmentally impaired endocardial population in HLHS through single-cell RNA profiling of hiPSC-derived endocardium and human fetal heart tissue with an underdeveloped left ventricle. Intrinsic endocardial defects contribute to abnormal endothelial-to-mesenchymal transition, NOTCH signaling, and extracellular matrix organization, key factors in valve formation. Endocardial abnormalities cause reduced cardiomyocyte proliferation and maturation by disrupting fibronectin-integrin signaling, consistent with recently described de novo HLHS mutations associated with abnormal endocardial gene and fibronectin regulation. Together, these results reveal a critical role for endocardium in HLHS etiology and provide a rationale for considering endocardial function in regenerative strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据